1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center


Stan Swartz, CEO,
The MD Health Channel

"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
"At 92...I had lost my will to live"
Tips on Aging
"Dr. Reyes gave me customized health care"

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
Runtime: 50:22
Runtime: 50:22
Runtime: 10:27
Runtime: 10:27
Runtime: 5:00
Runtime: 5:00
PDF Document 850 kb

Download Free

Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
Free Windows Media Player Click

Barrow Neurological Institute

October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  
June 2018  
July 2018  
August 2018  
September 2018  
October 2018  
November 2018  
December 2018  
January 2019  
February 2019  
March 2019  
April 2019  
May 2019  
June 2019  
July 2019  

This page is powered by Blogger. Isn't yours?

Friday, June 30, 2017


Rutgers Study Suggests New Biomarker for Alzheimer’s Induced by DDT Pesticide Exposure

[Photo: Mr. Héctor Maldonado-Pérez]

A Rutgers School of Public Health study conducted by alumnus, Mr. Héctor Maldonado-Pérez MPH’16, and faculty, found that DDT Pesticide exposure may influence Alzheimer’s Disease onset. There are many subtypes of dementia, but Alzheimer’s Disease continues to be the most common worldwide. The cause of Alzheimer’s Disease is not fully understood, however, genetic markers, such as the APOE4 allele, have been identified as potential biomarkers for the disease. The significance of the APOE4 allele’s presence varies by race. The presence of APOE4 is a better indicator of Alzheimer’s Disease in White individuals than in Hispanic or African American individuals.
Read more »


Thursday, June 29, 2017


There's a striking relationship between cancer and Alzheimer's, and it could hold the key to new treatments

Patients with Alzheimer's and dementia are sit inside the Alzheimer foundation in Mexico City Thomson Reuters

Alzheimer's disease affects about 5.5 million Americans — a number that's expected to balloon to 13.8 million by 2050.
Read more »

Wednesday, June 28, 2017


This human protein may unfurl toxic tangles in Alzheimer’s disease

Gene therapy that increases the levels of an enzyme called CyP40 can reduce toxic tangles of tau protein in a mouse model of Alzheimer’s disease (right panel versus control condition in left panel). Photo by Baker JD et al., PLOS Biology, 2017.

A human protein — called CyP40 — can untangle the neurodegenerative clumps that characterize Alzheimer’s and Parkinson’s diseases, scientists reported Tuesday in the journal PLoS Biology. The findings may guide new therapeutic avenues for these conditions.
Read more »

Tuesday, June 27, 2017


Spotting the Earliest Signs of Alzheimer's

Work is about to begin on a new study to find the earliest signs of Alzheimer's disease, many years before symptoms like memory loss and confusion become obvious.
Read more »

Monday, June 26, 2017


Alzheimer's disease study links brain health, physical activity

People at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have healthy patterns of glucose metabolism in their brain, according to a new UW-Madison study.
Credit: University of Wisconsin-Madison

Results of the research were published online in Journal of Alzheimer's Disease. Senior author Dr. Ozioma Okonkwo, assistant professor of medicine, is a researcher at the Wisconsin Alzheimer's Disease Research Center and the Wisconsin Alzheimer's Institute at the UW School of Medicine and Public Health. First author Ryan Dougherty is a graduate student studying under the direction of Dr. Dane B. Cook, professor of kinesiology and a co-author of the study, and Dr. Okonkwo. The research involved 93 members of the Wisconsin Registry for Alzheimer's Prevention (WRAP), which with more than 1,500 registrants is the largest parental history Alzheimer's risk study group in the world.
Read more »

Sunday, June 25, 2017


Mutation Contributes to Faster Progression of Alzheimer’s Disease, Study Reports

A mutation in the BDNF gene can accelerate loss of memory and cognitive function in people at risk of developing Alzheimer’s, according to a study.
Read more »

Saturday, June 24, 2017



Extra virgin olive oil is the key ingredient of the Mediterranean diet that protects the brain from Alzheimer’s disease and cognitive decline, scientists have discovered.
Read more »


Friday, June 23, 2017


What Can Prevent Alzheimer’s? Here’s What the Evidence Shows

Illustration of the thought processes in the brain  Getty Images/iStockphoto

There’s no strong evidence that anything prevents Alzheimer’s disease, but a few common-sense practices may help delay memory loss, a panel of experts said Thursday.
Read more »

Thursday, June 22, 2017


Extra-virgin olive oil may prevent Alzheimer's

New research explores the neurological benefits of extra-virgin olive oil and finds that it may help to prevent the onset of Alzheimer's disease.

New research suggests that extra-virgin olive oil - a key component of the Mediterranean diet - may protect the brain from Alzheimer's disease symptoms. 
Mouse experiments revealed changes in both cognitive performance and the appearance of nerve cells.

Alzheimer's disease is estimated to affect approximately 5 million people in the United States. The neurodegenerative disease is progressive and cannot yet be cured or reversed.
Read more »

Wednesday, June 21, 2017


Gene variant protecting against Alzheimer's disease decreases plasma beta-amyloid levels


New research from the University of Eastern Finland shows that the APP gene variant protecting against Alzheimer's disease significantly decreases plasma beta-amyloid levels in a population cohort. This is a very significant discovery, as many on-going drug trials in the field of Alzheimer's disease focus on decreasing beta-amyloid levels in the brain tissue. According to the study, a 30% life-long decrease in beta-amyloid levels is not associated with detrimental effects on lipid or glucose metabolism, or on any other metabolic factors.
Read more »


Tuesday, June 20, 2017


Alzheimers Q & A: What types of activities are best suited for those with Alzheimer's or dementia?

Image Source: DANABLOG

What types of activities are best suited for those with Alzheimer's or dementia?

It is important to match activities to interests and cognitive ability in order to increase participation and satisfaction for those with Alzheimer's disease or dementia. If they're not, it's unlikely that person will participate.
Read more »

Monday, June 19, 2017


Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease

By Professor Chris Exley

Abstract: In this paper, I have summarized the experimental and largely clinical evidence that implicates aluminum as a primary etiological factor in Alzheimer’s disease. The unequivocal neurotoxicity of aluminum must mean that when brain burdens of aluminum exceed toxic thresholds that it is inevitable that aluminum contributes toward disease. Aluminum acts as a catalyst for an earlier onset of Alzheimer’s disease in individuals with or without concomitant predispositions, genetic or otherwise. Alzheimer’s disease is not an inevitable consequence of aging in the absence of a brain burden of aluminum.
Read more »

Sunday, June 18, 2017


Alzheimers Q & A: Why is dad's head so itchy?

Image Source: HEALTHBLOG

Many people with Alzheimer's or dementia scratch themselves or constantly pick at their skin. The itching may be caused by a number of reasons, though oftentimes those with the disease begin to have obsessive-compulsive behaviors, which are difficult to curb.

Read more »

Saturday, June 17, 2017


Researchers Identify Metabolite That Could Signal a Higher Risk of Developing Dementia and Alzheimer’s

Higher levels of a molecule called anthranilic acid could signal that a person is at increased risk of developing dementia and Alzheimer’s disease, according to a study.
Read more »


Friday, June 16, 2017


Certain vitamins can help prevent age-related cognitive decline

Joshua Miller
Image Source: RUTGERS

(SACRAMENTO, Calif.) —

Joshua Miller, professor and chair of the Department of Nutritional Sciences at Rutgers, The State University of New Jersey, will speak about the role vitamins can play in preventing Alzheimer’s disease and dementia at a free public lecture on June 29 at 6 p.m. at the UC Davis MIND Institute, 2825 50th Street in Sacramento.
Read more »

Thursday, June 15, 2017


Study identifies potential biomarker for Alzheimer's disease


In one of the largest studies to date to use metabolomics, the study of compounds that are created through various chemical reactions in the body, researchers have been able to identify new circulating compounds associated with the risk of developing dementia and Alzheimer's disease (AD).
Read more »


Wednesday, June 14, 2017


Music and Memory Program Decreases Medication Use and Improves Dementia Symptoms, Study Finds

A new study found personalized music and memory therapy helped decrease antipsychotic and anti-anxiety medication use, as well as improve dementia symptoms, in people living with Alzheimer’s disease (AD) and related dementias (ADRD).
Read more »

Tuesday, June 13, 2017


Western diet increases Alzheimer's pathology in genetically predisposed mice

Credit: Christian J. Pike

Obese mice with a particular version of a gene strongly associated with Alzheimer's disease (AD) in humans show increased Alzheimer's pathology, according to new research published in eNeuro. The study suggests lifestyle changes could reduce the likelihood of developing AD in individuals with this genetic predisposition.
Read more »

Monday, June 12, 2017


Voice strong as mind fades, a country great says 'Adios'

Glen Campbell performing at the Staples Center during the 54th Grammy Awards in 2012 (AFP Photo/ROBYN BECK)

His mind succumbing to Alzheimer's disease, country legend Glen Campbell can still summon strength through his voice and he has seized on it to bid farewell to the world.
Read more »

Sunday, June 11, 2017


$800k grant to help Dell Seton study how to prevent Alzheimer’s: VIDEO

A new report recently released on Alzheimer’s disease resulted in new information from the Centers for Disease Control and Prevention.
Read more »

Saturday, June 10, 2017


A new study by researchers at the University of Montana, Universidad del Valle de México, Instituto Nacional de Pediatría, Boise State, and Universidad Nacional Autónoma de México, heightens concerns over the detrimental short- and long-term impact of airborne iron-rich strongly magnetic combustion-derived nanoparticles (CDNPs) present in young urbanites’ brains. Using transmission electron microscopy, the researchers documented by abundant combustion nanoparticles in neurons, glial cells, choroid plexus, and neurovascular units of Mexico City children, teens and young adults chronically exposed to concentrations above the US-EPA standards for fine particulate matter.
Read more »

Friday, June 9, 2017


Menopause, Memory And Alzheimer’s Disease

When women think about menopause, they typically think about hot flashes. New research shows that memory problems are a common but under-recognized menopausal symptom.
Read more »

Thursday, June 8, 2017


Bill Passed: Government To Microchip Disabled People Without Consent

Though the bill only targets those with conditions such as Alzheimers and autism, critics say the bill’s passage will open a “pandora’s box” of invasive government surveillance.

Six years ago, NBC Nightly News boldly predicted that all Americans would be fitted with RFID microchips by the year 2017. Though at the time, NBC’s prediction seemed far-fetched, the House recently passed a bill that would bring a micro-chipped populace closer to reality before year’s end. Last Thursday, the House passed HR 4919, also known as Kevin and Avonte’s Law, which would allow the US attorney general to award grants to law enforcement for the creation and operation of “locative tracking technology programs.” Though the program’s mission is to find “individuals with forms of dementia or children with developmental disabilities who have wandered from safe environments,” it provides no restriction on the tracking programs inclusion of other individuals. The bill would also require the attorney general to work with the secretary of health and human services and unnamed health organizations to establish the “best practices” for the use of tracking devices.
Read more »

Wednesday, June 7, 2017


Alzheimer’s disease: Reduce the risk

Shutterstock Image

If you think you or a loved one is experiencing more serious cognitive function issues, including memory problems, it is important to see your doctor.

Some mild forgetfulness is normal as we age. But if you think you or a loved one is experiencing more serious cognitive function issues, including memory problems, it is important to see your doctor.
Read more »

Tuesday, June 6, 2017


Rising Alzheimer's Death Correlates To Awareness: VIDEO

The Centers for Disease Control and Prevention found in a recent report that the number of deaths credited to Alzheimer's disease has increased by more than half. Experts say the report, which is based on data from death certificates, suggests diagnosis of the disease has improved -- as has treatment of other leading causes of death in the United States. Christopher A. Taylor, an epidemiologist at the CDC, told UPI, "People are becoming more aware of Alzheimer's disease and go to physicians to seek out a diagnosis if they have symptoms." Wichita
Story Source: The above story is based on materials provided by SCITIMES
Note: Materials may be edited for content and length


Monday, June 5, 2017


Epileptic-seizure-like activity in a brain region called the hippocampus may contribute to the development of Alzheimer’s, according to a case study involving two patients.
Read more »

Sunday, June 4, 2017


Aerobic Exercise Reverses Alzheimer Symptoms


Aerobic exercise can reverse the cognitive decline typical of Alzheimer's disease, at least in the short term, a new meta-analysis suggests.
Read more »

Saturday, June 3, 2017


9 Ways to Reduce Your Risk of Alzheimer's

Maria Shriver, in her office. (Azusa Takano / Azusa Takano)

The statistics on women and Alzheimer’s disease are startling.

Every 66 seconds someone in the U.S. develops Alzheimer’s. Two-thirds are women, according to the Alzheimer’s Assn.
Read more »

Friday, June 2, 2017


Alzheimer's Caregivers: Isolated And Needing Help

Credit: Shutterstock

Fifteen million Americans care for a loved one with Alzheimer’s or another dementia, and two-thirds of them feel isolated or alone in that difficult endeavor.
Read more »

Thursday, June 1, 2017


New connection sprouts between Alzheimer's disease and the immune system: VIDEO

High-resolution confocal images from the hippocampal CA3 region of Alzheimer's mouse brain show amyloid-beta plaques (green) and microglia/macrophages (red). Mice with complement C3 deficiency show an altered glial response to plaques. Credit: the Lemere Lab, Brigham and Women's Hospital

Just as trimming back the branches of an overgrown plant can encourage healthy growth, a little pruning of the connections in the human brain can be a good thing during brain development. But what happens when this natural process goes wrong later in life? Investigators at Brigham and Women's Hospital have found new clues from preclinical models to indicate that this "synaptic refinement" may play a role in neurodegenerative disease. Their findings, published in Science Translational Medicine, offer new insights into the interplay between the immune system and the development of Alzheimer's disease.
Read more »